<DOC>
	<DOC>NCT00040495</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of intravenous pantoprazole in the prevention of rebleeding in patients with bleeding peptic ulcer disease after successful endoscopic hemostatic therapy.</brief_summary>
	<brief_title>Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Patients must be men or nonpregnant women at least 18 years of age Patients who present with a gastric or duodenal ulcer Patients with ulcer appearance of clean base (nonoozing, nonspurting) or flat pigmented spot; adherent clots not removed by irrigation Patients presenting with active bleeding and/or NBVV at 2 or more separate sites Patients with any severe concomitant diseases, eg, end stage liver or renal disease, or unstable cardiovascular, pulmonary, renal, hepatic, or gastrointestinal diseases</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Peptic</keyword>
	<keyword>Ulcer</keyword>
	<keyword>Hemorrhage</keyword>
</DOC>